about
Parkinson's disease and primate research: past, present, and futureComputational Modeling and Neuroimaging Techniques for Targeting during Deep Brain StimulationMRI-Guided Focused Ultrasound in Parkinson's Disease: A ReviewActivation of the central nervous system induced by micro-magnetic stimulation.Site of deep brain stimulation and jaw velocity in Parkinson disease.Deep brain stimulation activation volumes and their association with neurophysiological mapping and therapeutic outcomesStudies of properties of "Pain Networks" as predictors of targets of stimulation for treatment of pain.Effects of depression and social support on comprehension and recall of informed consent information among Parkinson disease patients and their caregiversPre- and post- GPi DBS neuropsychological profiles in a case of X-linked dystonia-Parkinsonism.Deep brain stimulation does not silence neurons in subthalamic nucleus in Parkinson's patientsDeep brain stimulation and cognitive decline in Parkinson's disease: a clinical review.Testing the contributions of striatal dopamine loss to the genesis of parkinsonian signsNew therapeutic approaches to Parkinson's disease including neural transplants.Fiber tractography of the axonal pathways linking the basal ganglia and cerebellum in Parkinson disease: implications for targeting in deep brain stimulation.Cell therapy for Parkinson's disease: only young onset patients allowed? Reflections about the results of recent clinical trials with cell therapy and the progression of Parkinson's disease.Pallidal burst activity during therapeutic deep brain stimulation.Deep brain stimulation and the role of the neuropsychologist.Tissue and electrode capacitance reduce neural activation volumes during deep brain stimulationDeep brain stimulation: indications and evidence.Computational analysis of deep brain stimulation.Neural interfaces at the nanoscaleCurrent steering to control the volume of tissue activated during deep brain stimulation.Glutamate receptors as therapeutic targets for Parkinson's disease.Virtual reality feedback cues for improvement of gait in patients with Parkinson's disease.Computational modeling of deep brain stimulation.Use of genetically modified mesenchymal stem cells to treat neurodegenerative diseases.Unusual complications of deep brain stimulation.Intrinsic dynamics and synaptic inputs control the activity patterns of subthalamic nucleus neurons in health and in Parkinson's disease.Can Cyclic Nucleotide Phosphodiesterase Inhibitors Be Drugs for Parkinson's Disease?Sequence of electrode implantation and outcome of deep brain stimulation for Parkinson's disease.Computational analysis of subthalamic nucleus and lenticular fasciculus activation during therapeutic deep brain stimulation.Neuropsychological performance following staged bilateral pallidal or subthalamic nucleus deep brain stimulation for Parkinson's disease.Inhibitory effects of curcumin and cyclocurcumin in 1-methyl-4-phenylpyridinium (MPP+) induced neurotoxicity in differentiated PC12 cells.Electrophysiological and behavioral effects of group III metabotropic glutamate receptors on pallidal neurons in normal and parkinsonian rats.Role of clinical neuropsychology in deep brain stimulation: Review of the literature and considerations for clinicians.Effects of nigral stimulation on locomotion and postural stability in patients with Parkinson's disease.Hybrid learning control for improving suppression of hand tremor.Surgical insights into Parkinson's disease.
P2860
Q24655590-F2CAA03B-4C5C-4E1D-A1B3-147B3C5B5EE5Q26738409-77EAED78-5979-4BC0-AAD9-B9FFA3189DC5Q30357442-2902D3E2-E42A-4C1E-9C00-00A999A29F43Q30441778-3C01B68A-6009-4E5D-B64A-FC67930C4261Q30459981-9ED983F9-075E-4B83-847B-EC5EDF4105B1Q33809687-FE2CAF0C-2F40-41C1-8183-52410E643273Q34098850-8555023C-56C2-44B3-8628-9962229ED19EQ34102890-25914DDE-BD52-44D4-BA1E-6A24069C4793Q34758993-94498796-23CE-4BFE-B9A7-23F58B6420D8Q35122590-308499FA-3696-4F0E-84EF-70A7CF2923D0Q35914879-740715F2-863D-4FF2-87AF-D047883DBB13Q35980553-BA57115B-9771-46BE-8893-3B4214A902CFQ36225073-3360FF71-4F40-496A-BACE-FBB5C0AD5E39Q36450444-B969BC1E-88B9-4585-BBE5-3D18E7D8FED7Q36660994-183C6204-9E02-413E-9005-BE7E0A26502BQ36727455-99F349BE-6569-41D3-8BC8-EB09982A72DBQ36762186-B22BF155-8F0D-42AE-9B9D-3E6619F638EBQ36841883-2E11F578-1E0F-487C-9980-42E81BBB0C30Q36938330-C3FDD65C-A6BF-4A79-8F0C-4F225F993292Q36938339-D39CABA0-4E2E-478E-AEEB-8AE4BD1C21AEQ36999787-B61EDDF7-AF6F-4621-9A93-9C0646CEA99BQ37052074-621ED1E5-CFF9-4F32-AC9C-AC1FC8657C4FQ37585401-38E0344F-A12B-4971-BAA6-B82B715551B3Q37676892-EDD92A27-DA16-43A5-9F90-C73CA380A0DAQ38151314-9561F47A-4CF7-425F-8F1F-42F56A76CEF0Q38181868-7A6B7379-6400-45EE-9F98-A3D3DA72057DQ38262436-3650B059-719F-46A7-9E9B-E7E54EBC83EDQ38905916-8D561DB2-1A64-4E42-A73E-2A17974205ABQ39072124-E4F4B20E-8CEA-4487-B58F-A1656C48B7ADQ40556508-3910B180-49D3-46A7-B83C-6E0F4FF2F20CQ42496222-58858603-0BBD-4E76-A5F6-48AE406CD4AEQ45986458-DFB9A171-57EE-4C23-BB78-34838A6ED07DQ46247320-C0063E86-09A1-4244-8113-34A307579615Q46771144-CB2445CD-0B35-4406-93C8-2E7AE90777AFQ47918128-93D31B1A-344E-4345-BEB5-13D646290141Q48831596-94800C37-2899-48D8-AD8E-2E3503B48B83Q50249707-244A5464-28F1-42B4-88B4-546AA09115ADQ51211712-AB448CCF-4217-433E-BA3E-7B5A4045154B
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Surgical treatment for Parkinson's disease.
@ast
Surgical treatment for Parkinson's disease.
@en
type
label
Surgical treatment for Parkinson's disease.
@ast
Surgical treatment for Parkinson's disease.
@en
prefLabel
Surgical treatment for Parkinson's disease.
@ast
Surgical treatment for Parkinson's disease.
@en
P1433
P1476
Surgical treatment for Parkinson's disease.
@en
P2093
Benjamin L Walter
Jerrold L Vitek
P304
P356
10.1016/S1474-4422(04)00934-2
P577
2004-12-01T00:00:00Z